Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation
However, the use of peptides for weight loss is not without risks
It was developed by Novo Nordisk and described by Raun et al
It is well-documented for aiding healing in tendons, ligaments, and muscles, and may also protect the gut lining and improve intestinal integrity
Studies have examined ipamorelin in models of lean mass accretion, visceral fat reduction, and metabolic syndrome, with findings consistent with the broader GH/IGF-1 axis literature
In research discussions, its usually framed as a repair and inflammation-focused blend rather than a single-pathway tool